ResearchKit is being touted as having immense implications for the future of clinical trials.
A new study has discovered the trigger behind the most severe forms of cancer pain.
Animal model of breast-to-brain cancer spread allows testing of therapeutic-cell approach.
A recent analysis of long-term after-effects of a specific hormone replacement therapy (HRT)—...
Implantable device could allow doctors to test cancer drugs in patients before prescribing chemotherapy.
New research shows that high-grade gliomas, the deadliest human brain tumors, increase their growth by hijacking some of the machinery of neuroplasticity, which normally helps the brain form new synapses.
A new study has found dramatic improvements in the care of patients with cirrhosis and liver failure and recommends improved treatment strategies for patients with cirrhosis and concurrent bacterial infections.
This method is delivering some promising results in early trials.
One of the main sessions at this year’s Experimental Biology Conference in Boston was the Tang Prize Award lecture.
A single cell type in the skin of mice is a major contributor to scarring after wound healing or radiation damage, and facilitates the growth of melanoma. Blocking the cell’s activity in humans may be possible with currently approved drugs.
Research suggests strategy to prevent relapse after therapies targeting tumor blood vessels.
Study Describes First Steps in Basic Biological Process that Could Be Used to Harness Therapeutic CellsApril 17, 2015 2:23 pm | by University of Penn Medicine | News | Comments
Understanding the molecular signals that guide early cells in the embryo to develop into different types of organs provides insight into how tissues regenerate and repair themselves.
Dartmouth researchers identify precise heat to boost immune system against cancer tumors.
Findings identify a cause of the disease and highlight potential therapeutic approach.
More cancer patients are getting the genes in their tumors mapped to help guide their treatment. New research suggests that isn't always accurate enough, and a second test could help ferret out the culprit genes.
A wearable device that emits low-level electrical fields can slow the progression of glioblastoma, the deadliest form of brain cancer, and extend patients’ lifespans.
As personalized medicine is integrated into mainstream medical treatment, sequencing clinically relevant genes using the latest next generation sequencing (NGS) technologies will prove instrumental in guiding clinicians towards informed treatment decisions.
Stimulating both major branches of the immune system halts tumor growth more effectively.
Researchers at Brown and URI have demonstrated what could be a more precise method for targeting cancer cells for radiation. Cancer-seeking peptides ferry nanoparticles of gold to the site. The gold then helps focus radiation on the cancer cells.
Li Xiaohe has set herself up for the long haul in a cramped but sunny room in western Beijing, about a block from China's most renowned cancer hospital. Her laundry dries on hangers and her husband cooks in a communal kitchen as she embarks on an 84-day program of chemotherapy, following the removal of part of her right breast.
A UNC Lineberger-led study found that people with higher-risk melanoma containing either BRAF or NRAS gene mutations had lower survival rates.
A test for a wide range of genetic risk factors could improve doctors’ ability to work out which women are at increased risk of developing breast cancer, a major study of more than 65,000 women has shown.
Discovery could offer a new target for treatment of glioblastoma.
Moffitt Cancer Center researchers discovered a novel mechanism that plays an important role in the maintenance of lung cancer stem cells. This finding may lead to new potential therapeutic targets.
The first personalized cancer vaccine using genomics to define targets elicits robust immune responses, says a recent Science study.
Acoustic device can rapidly isolate circulating tumor cells from patient blood samples.
New therapy approach goes directly to the source of cancer development.
The body's immune system fights disease, infections and even cancer, acting like foot soldiers to protect against invaders and dissenters.
Fasting in combination with chemotherapy has already been shown to kill cancer cells, but a pair of new studies in mice suggests that a less-toxic class of drugs combined with fasting may kill breast, colorectal and lung cancer cells equally well.
- Page 1